Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12600785 | Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene | 🖼🧊📄§ | 2026-04-14 | 2041-02-15 | 0 | 31 |
| 12600784 | Anti-Clec12A antibodies and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-04-25 | 0 | 31 |
| 12600788 | Compositions and methods for treatment of thyroid eye disease | 🖼🧊📄§ | 2026-04-14 | 2045-06-18 | 0 | 31 |
| 12600758 | Interleukin-2 muteins for the expansion of T-regulatory cells | 🖼🧊📄§ | 2026-04-14 | 2040-08-13 | 0 | 31 |
| 12600713 | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide | 🖼🧊📄§ | 2026-04-14 | 2044-02-27 | 0 | 31 |
| 12600727 | Treatment of infections of toxoplasma gondii and closely related parasites | 🖼🧊📄§ | 2026-04-14 | 2039-09-18 | 0 | 31 |
| 12599633 | Mesenchymal stem cells for use in the treatment of skin defects | 🖼🧊📄§ | 2026-04-14 | 2042-05-20 | 0 | 31 |
| 12599636 | Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression | 🖼🧊📄§ | 2026-04-14 | 2038-01-19 | 0 | 31 |
| 12599637 | Genetically modified Lactobacillus and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-04 | 0 | 31 |
| 12599641 | Probiotic composition for improving soy protein proteolysis and amino acid production activity | 🖼🧊📄§ | 2026-04-14 | 2044-05-28 | 0 | 31 |
| 12599643 | Use of green coffee based compositions for improving insulin profile | 🖼🧊📄§ | 2026-04-14 | 2040-03-27 | 0 | 31 |
| 12599646 | Peptide-containing composition for use for treating neoplastic lesions | 🖼🧊📄§ | 2026-04-14 | 2040-03-10 | 0 | 31 |
| 12599644 | Treatment of coronavirus infection with Flt3 receptor interacting lectin (FRIL) | 🖼🧊📄§ | 2026-04-14 | 2041-05-06 | 0 | 31 |
| 12599650 | Inhibition of SIRP-gamma for cancer treatment | 🖼🧊📄§ | 2026-04-14 | 2040-06-23 | 0 | 31 |
| 12599653 | Thrombolytic agents for intravascular clots | 🖼🧊📄§ | 2026-04-14 | 2040-10-19 | 0 | 31 |
| 12599656 | Methods for treating HPV-associated diseases | 🖼🧊📄§ | 2026-04-14 | 2039-03-11 | 0 | 31 |
| 12599660 | Therapeutic RNA for HPV-positive cancer | 🖼🧊📄§ | 2026-04-14 | 2041-07-06 | 0 | 31 |
| 12599668 | Antibodies | 🖼🧊📄§ | 2026-04-14 | 2040-02-20 | 0 | 31 |
| 12599663 | Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation | 🖼🧊📄§ | 2026-04-14 | 2039-03-08 | 0 | 31 |
| 12599670 | Composition comprising three-dimensional astrocyte bundles of bi-polar and aligned astrocyte processes and a method of making thereof | 🖼🧊📄§ | 2026-04-14 | 2035-12-11 | 0 | 31 |
| 12599680 | Treatments for ocular neovascularization | 🖼🧊📄§ | 2026-04-14 | 2045-08-14 | 0 | 31 |
| 12599676 | Cytotoxic imidazo[1,2-A]pyridine compounds and their use in therapy | 🖼🧊📄§ | 2026-04-14 | 2045-03-06 | 0 | 31 |
| 12599679 | Circular RNA compositions | 🖼🧊📄§ | 2026-04-14 | 2045-05-07 | 0 | 31 |
| 12599677 | Targeted PH sensitive liposomes | 🖼🧊📄§ | 2026-04-14 | 2041-10-04 | 0 | 31 |
| 12599683 | Mapping nanoparticles | 🖼🧊📄§ | 2026-04-14 | 2042-05-12 | 0 | 31 |
| 12599685 | Tumor stroma imaging agent and preparation method thereof | 🖼🧊📄§ | 2026-04-14 | 2040-10-13 | 0 | 31 |
| 12599607 | Pharmaceutical compositions comprising timolol | 🖼🧊📄§ | 2026-04-14 | 2044-07-19 | 0 | 31 |
| 12599621 | Enhancing anti-tumor response in melanoma cells with defective sting signaling | 🖼🧊📄§ | 2026-04-14 | 2041-01-21 | 0 | 31 |
| 12599619 | Method of treating blepharitis or conjunctivitis | 🖼🧊📄§ | 2026-04-14 | 2042-05-03 | 0 | 31 |
| 12599624 | Biodegradable lung sealants | 🖼🧊📄§ | 2026-04-14 | 2042-08-30 | 0 | 31 |
| 12599626 | Method of obtaining a pharmaceutical agent used for inhibiting the proliferation of tumor cells | 🖼🧊📄§ | 2026-04-14 | 2042-01-10 | 0 | 31 |
| 12599599 | Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof | 🖼🧊📄§ | 2026-04-14 | 2043-07-20 | 0 | 31 |
| 12599597 | Substituted N-benzhydrylacetamide inhibitors of jumanji domain histone demethylases for the treatment of cancer | 🖼🧊📄§ | 2026-04-14 | 2041-03-04 | 0 | 31 |
| 12599575 | Antimicrobial adjuvant containing biphenyl derivative compound as active ingredient, and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-01-28 | 0 | 31 |
| 12599573 | Compositions and uses thereof in treating cancers | 🖼🧊📄§ | 2026-04-14 | 2043-03-17 | 0 | 31 |
| 12599577 | Thermoresponsive gel eye drop for ocular delivery of cysteamine | 🖼🧊📄§ | 2026-04-14 | 2039-11-18 | 0 | 31 |
| 12599584 | Indoline derivatives, compositions comprising them and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2037-01-19 | 0 | 31 |
| 12599586 | Edaravone suspension for oral administration | 🖼🧊📄§ | 2026-04-14 | 2044-03-26 | 0 | 31 |
| 12599585 | Use of [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate in combination therapy | 🖼🧊📄§ | 2026-04-14 | 2043-04-13 | 0 | 31 |
| 12599581 | Method of treating expressive language deficit in autistic humans | 🖼🧊📄§ | 2026-04-14 | 2044-03-29 | 0 | 31 |
| 12599583 | Small molecule GRB2 stabilizers for Ras map kinase inhibition | 🖼🧊📄§ | 2026-04-14 | 2040-03-13 | 0 | 31 |
| 12599591 | Vemurafenib and salts thereof for use in the treatment of enteroviral infections | 🖼🧊📄§ | 2026-04-14 | 2039-10-03 | 0 | 31 |
| 12599323 | Methods and systems for treating pregnancy-related hypertensive disorders comprising anti-sEng and anti-sFlt-1 antibodies | 🖼🧊📄§ | 2026-04-14 | 2040-12-08 | 0 | 31 |
| 12595307 | Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors | 🖼🧊📄§ | 2026-04-07 | 2041-06-09 | 0 | 31 |
| 12594245 | Dry powder formulations for messenger RNA | 🖼🧊📄§ | 2026-04-07 | 2042-05-16 | 0 | 31 |
| 12595469 | Treatment of retinitis pigmentosa using improved engineered meganucleases | 🖼🧊📄§ | 2026-04-07 | 2041-05-11 | 0 | 31 |
| 12596122 | LILRB2 antibodies and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-01-28 | 0 | 31 |
| 12595481 | Methods and compositions for neuroprotection | 🖼🧊📄§ | 2026-04-07 | 2040-11-25 | 0 | 31 |
| 12595259 | Aminopyridine compound | 🖼🧊📄§ | 2026-04-07 | 2041-06-17 | 0 | 31 |
| 12595289 | Therapeutic agent for breast cancer comprising BIG3-PHB2 interaction-inhibiting peptide derived from PHB2 | 🖼🧊📄§ | 2026-04-07 | 2039-11-28 | 0 | 31 |